Related Experiment Video
Updated: Aug 12, 2026

11:36
A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunction
L Patel1, C D Cooper, N D Quinton
1Department of Child Health, University of Manchester, Booth Hall Children's Hospital, UK. lp@man.ac.uk
Journal of Pediatric Endocrinology & Metabolism : JPEM
|August 30, 2002
Summary
Hypothalamic damage in children can cause eating disturbances and obesity due to impaired leptin feedback. Studies show altered leptin levels and binding activity, suggesting central leptin insensitivity in these patients.
Area of Science:
- Pediatric Endocrinology
- Neuroendocrinology
- Obesity Research
Background:
- Hypothalamic damage frequently leads to eating behavior disturbances and obesity.
- Leptin is a key hormone regulating appetite and energy balance, with central feedback mechanisms crucial for its action.
Purpose of the Study:
- To investigate the association between hypothalamic-pituitary axis damage and dysfunctional leptin central feedback in children.
- To evaluate serum leptin levels and leptin binding activity in patients with hypothalamic damage compared to healthy controls.
Main Methods:
- Serum leptin and leptin binding activity were measured in 37 patients with hypothalamic-pituitary axis damage (tumors or trauma) and 138 healthy children.
- Patients were categorized by Body Mass Index (BMI) standard deviation scores (SDS) (<2 SDS or ≥2 SDS).
- Comparisons were made between patient subgroups and age/pubertal status-matched healthy children and children with simple obesity.
Main Results:
- Patients with hypothalamic damage exhibited higher BMI (1.9 vs 0.2 SDS) and serum leptin levels (2.1 vs 0.04 SDS) compared to healthy children.
- Non-obese patients (BMI <2 SDS) showed higher serum leptin and leptin adjusted for BMI, suggesting unrestrained leptin secretion.
- Leptin binding activity and values adjusted for BMI were lower in patients, indicating potentially higher free leptin levels and central leptin insensitivity.
Conclusions:
- Markedly elevated leptin levels in non-obese patients with hypothalamic damage suggest dysregulated leptin secretion.
- Lower leptin binding activity in these patients may lead to increased free leptin, consistent with central leptin insensitivity.
- These findings highlight potential mechanisms linking hypothalamic damage to obesity and eating disturbances via leptin signaling pathways.
More Related Videos
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

